The Galien Foundation has revealed its latest nominees for the 2021 Prix Galien USA Award highlighting innovations in biotechnology, pharmaceutical agents, medical technology and digital health products. Entrants to the competition must have received FDA approval within the past five years and demonstrate exceptional therapeutic potential. The Galien Foundation does not use financial data to…
Zokinvy: The first FDA-approved drug to treat Hutchinson-Gilford progeria syndrome
In November, 2020, Zokinvy (lonafarnib) from Eiger BioPharmaceuticals became the first drug to win FDA approval to lower the risk of death resulting from Hutchinson-Gilford progeria syndrome, a progressive genetic disorder that leads to rapid aging in children. The FDA indication also covered the treatment of some processing-deficient progeroid laminopathies in patients one year of age…